181 related articles for article (PubMed ID: 37344100)
21. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Buqué A; Bloy N; Perez-Lanzón M; Iribarren K; Humeau J; Pol JG; Levesque S; Mondragon L; Yamazaki T; Sato A; Aranda F; Durand S; Boissonnas A; Fucikova J; Senovilla L; Enot D; Hensler M; Kremer M; Stoll G; Hu Y; Massa C; Formenti SC; Seliger B; Elemento O; Spisek R; André F; Zitvogel L; Delaloge S; Kroemer G; Galluzzi L
Nat Commun; 2020 Jul; 11(1):3819. PubMed ID: 32732875
[TBL] [Abstract][Full Text] [Related]
22. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
Chen IX; Newcomer K; Pauken KE; Juneja VR; Naxerova K; Wu MW; Pinter M; Sen DR; Singer M; Sharpe AH; Jain RK
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23684-23694. PubMed ID: 32907939
[TBL] [Abstract][Full Text] [Related]
23. An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation.
Fu Y; Tian G; Li J; Zhang Z; Xu K
Int J Mol Med; 2020 Oct; 46(4):1501-1513. PubMed ID: 32700748
[TBL] [Abstract][Full Text] [Related]
24. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
Efeyan A; Fabris V; Merani S; Lanari C; Molinolo AA
Breast Cancer Res Treat; 2004 Feb; 83(3):233-44. PubMed ID: 14758093
[TBL] [Abstract][Full Text] [Related]
25. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
26. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
27. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].
Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA
Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344
[TBL] [Abstract][Full Text] [Related]
28. Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
Tanegashima T; Togashi Y; Azuma K; Kawahara A; Ideguchi K; Sugiyama D; Kinoshita F; Akiba J; Kashiwagi E; Takeuchi A; Irie T; Tatsugami K; Hoshino T; Eto M; Nishikawa H
Clin Cancer Res; 2019 Aug; 25(15):4808-4819. PubMed ID: 31076547
[TBL] [Abstract][Full Text] [Related]
29. Progesterone promotes immunomodulation and tumor development in the murine mammary gland.
Werner LR; Gibson KA; Goodman ML; Helm DE; Walter KR; Holloran SM; Trinca GM; Hastings RC; Yang HH; Hu Y; Wei J; Lei G; Yang XY; Madan R; Molinolo AA; Markiewicz MA; Chalise P; Axelrod ML; Balko JM; Hunter KW; Hartman ZC; Lange CA; Hagan CR
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33958486
[TBL] [Abstract][Full Text] [Related]
30. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
31. Reversal of estrogen-resistance in murine mammary adenocarcinomas.
Montecchia MF; Molinolo A; Lanari C
Breast Cancer Res Treat; 1999 Mar; 54(2):93-9. PubMed ID: 10424399
[TBL] [Abstract][Full Text] [Related]
32. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
[TBL] [Abstract][Full Text] [Related]
33. Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
Kordon E; Lanari C; Molinolo AA; Elizalde PV; Charreau EH; Dosne Pasqualini C
Int J Cancer; 1991 Dec; 49(6):900-5. PubMed ID: 1835715
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.
Babikr F; Wan J; Xu A; Wu Z; Ahmed S; Freywald A; Chibbar R; Wu Y; Moser M; Groot G; Zhang W; Zhang B; Xiang J
Cell Mol Immunol; 2021 Dec; 18(12):2632-2647. PubMed ID: 34782757
[TBL] [Abstract][Full Text] [Related]
35. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
[TBL] [Abstract][Full Text] [Related]
36. Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride.
Wiebe JP; Rivas MA; Mercogliano MF; Elizalde PV; Schillaci R
J Steroid Biochem Mol Biol; 2015 May; 149():27-34. PubMed ID: 25595041
[TBL] [Abstract][Full Text] [Related]
37. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.
Kordon E; Lanari C; Meiss R; Elizalde P; Charreau E; Dosne Pasqualini C
Breast Cancer Res Treat; 1990 Nov; 17(1):33-43. PubMed ID: 2151368
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.
Sequeira GR; Sahores A; Dalotto-Moreno T; Perrotta RM; Pataccini G; Vanzulli SI; Polo ML; Radisky DC; Sartorius CA; Novaro V; Lamb CA; Rabinovich GA; Salatino M; Lanari C
Cancer Res; 2021 Mar; 81(5):1375-1387. PubMed ID: 33268529
[TBL] [Abstract][Full Text] [Related]
40. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment
Park S; Oh JH; Park DJ; Zhang H; Noh M; Kim Y; Kim YS; Kim H; Kim YM; Ha SJ; Kwon YG
Front Immunol; 2020; 11():620166. PubMed ID: 33584714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
